The effects of a fixed combination of 0.5% timolol and 1% dorzolamide on optic nerve head blood circulation

Journal of Ocular Pharmacology and Therapeutics

Volumn 28, Issue 4, 2012, Pages 392-396

  Ohguro, Ikuyo ^a   Ohguro, Hiroshi ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DORZOLAMIDE; DORZOLAMIDE PLUS TIMOLOL MALEATE; SODIUM CHLORIDE; TIMOLOL MALEATE;

ADULT; ARTICLE; BLOOD PRESSURE; CIRCULATION; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; EYE; EYE BLOOD FLOW; FEMALE; FLOW CYTOMETRY; HEART RATE; HUMAN; HUMAN EXPERIMENT; INTRAOCULAR PRESSURE; JAPANESE; LASER SPECKLE FLOWGRAPHY; MALE; NORMAL HUMAN; OCULAR PERFUSION; OPTIC NERVE; OPTIC NERVE HEAD BLOOD CIRCULATION; ORGAN PERFUSION; SYSTEMIC BLOOD PRESSURE;

ADMINISTRATION, TOPICAL; ADRENERGIC BETA-ANTAGONISTS; BLOOD PRESSURE; CARBONIC ANHYDRASE INHIBITORS; DRUG COMBINATIONS; DRUG SYNERGISM; EYE; FEMALE; HEART RATE; HUMANS; INTRAOCULAR PRESSURE; MALE; OPHTHALMIC SOLUTIONS; OPTIC DISK; PERFUSION; REGIONAL BLOOD FLOW; SULFONAMIDES; THIOPHENES; TIMOLOL; YOUNG ADULT;

EID: 84864576772     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2011.0243     Document Type: Article

References (25)

1. Shields, M.B. An overview of Glaucoma In: Shields MB, ed. Textbook of Glaucoma 4th ed. Baltimore, MD: Williams & Wilkins; 1988; p. 1-2.
2. Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am. J. Ophthalmol. 126:487-497, 1998.
3. Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension Glaucoma Am. J. Ophthalmol. 126: 498-505, 1998.
4. The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS):7. The relationship between control of intraocular pressure and visual field deterioration. Am. J. Ophthalmol. 130:429-440, 2000.
5. Heijl, A., Leske, M.C., Bengtsson, B., et al. Early Manifest Glaucoma Trial Group: Reduction of intraocular pressure and glaucoma progression: Results from the Early Manifest Glaucoma Trial. Arch. Ophthalmo. 120:1268-1279, 2002.
6. Martínez, A., and Sanchez-Salorio, M. A comparison of the long-term effects of dorzolamide 2% and brinzolamide 1%, each added to timolol 0.5%, on retrobulbar hemodynamics and intraocular pressure in open-angle glaucoma patients. J. Ocul. Pharmacol. Ther. 25:239-248, 2009.
7. Koseki, N., Araie, M., Tomidokoro, A., et al. A placebocontrolled 3-year study of a calcium blocker on visual field and ocular circulation in glaucoma with low-normal pressure. Ophthalmology 115:2049-2057, 2008.
8. Fuchsjäger-Maryl, G., Wally, B., Rainer, G., et al. Effect of dorzolamide and timolol on ocular blood flow in patients with primary open angle glaucoma and ocular hypertension. Br. J. Ophthalmol. 89:1293-1297, 2005.
9. Rolle, T., Tofani, F., Brogliatti, B., and Grignolo, F.M. The effects of dorzolamide 2% and dorzolamide/timolol fixed combination on retinal and optic nerve head blood flow in primary open-angle glaucoma patients. Eye 22:1172-1179, 2008.
10. Martínez, A., and Sanchez-Salorio, M. Predictors for visual field progression and the effects of treatment with dorzolamide 2%or brinzolamide 1% each added to timolol 0.5% in primary openangle Glaucoma Acta. Ophthalmol. 88:541-552, 2010.
11. Martínez, A., Gonzalez, F., Capeans, C., et al. Dorzolamide effect on ocular blood flow. Invest. Ophthalmol. Vis. Sci. 40:1270-1275, 1999.
12. Emi, K. The effects of dorzolamide on ocular blood circulation in normal- tension Glaucoma J. Eye : 18255-257, 2001.
13. Ohguro, I., Katai, M., Tanaka, S., Tsuruta, M., and Ohguro, H. Blood flow in the optic nerve head following instillation of 1% dorzolamide in eyes with Glaucoma Jpn. J. Clin. Ophthalmol. 64 : 921-926, 2010.
14. Omori, M., and Naito, K. Pharmacology and clinical effects of dorzolamide hydrochloride (Torusopt- Ophthalmic Solution). Jpn. J. Ocul.Pharmacol. 15:9-15, 2001.
15. Supuran, C.T. Carbonic anhydrase inhibitors and activators for novel therapeutic applications. Future Med. Chem. 3:1165-1180, 2011.
16. Wistrand, P.J., Schenholm, M., and Lonnerholm, G. Carbonic anhydrase isozymes CA I and CA II in human Eye Invest. Ophthalmol. Vis. Sci. 27:419-428, 1986.
17. Hargeman, G.S., Zhu, X.L., Waheed, A., et al. Localization of carbonic anhydrase IV in a specific capillary bed of the human Eye Proc. Natl. Acad. Sci. U.S.A. 88:2716-2720, 1991.
18. Krupin, T., Sly, W.S., Whyte, M.P., et al. Failure of acetazolamide to decrease intraocular pressure in patientwith carbonic anhydrase II deficiency. Am. J. Ophthalmol. 99:396-399, 1985.
19. Taki, K., Kato, H., Endo, S., et al. Cascade of acetazolamideinduced vasodilation. Res. Commun. Mol. Path. Pharmacol. 103:240-248, 1999.
20. Grunwald, J.E. Effect of timolol maleate on the retinal circulation of human eyes with ocular hypertension. Invest. Ophthalmol. Vis. Sci. 33:604-610, 1992.
21. Tamaki, Y., Araie, M., Tomita, K., et al. Effect of topical betablockers on tissue blood flow in the human optic nerve head. Curr. Eye Res. 16:1102-1110, 1997.
22. Yoshida, A., Feke, G.T., Ogasawara, H., et al. Effect of timolol on human retinal, choroidal and optic nerve head circulation. Ophthalmic. Res. 23:162-170, 1991.
23. Martínez, A., and Sánchez-Salorio, M. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: A single-center, 4-year, open-label study. Clin. Ther. 30:1120-1134, 2008.
24. Fuchjäger-Mayrl, G., Georgopoulos, M., Hommer, A., et al. Effect of dorzolamide and timolol on ocular pressure: blood flow relationship in patients with primary open-angle glaucoma and ocular hypertension. Invest. Ophthalmol. Vis. Sci. 51:1289-1296, 2010.
25. Ohguro, I., Katai, M., Tanaka, S., Tsuruta, M., Ohguro, H. Dorzolamide 1% added to latanoprost or timolol maleate 0.5% : Effect on optic nerve head blood flow in Glaucoma J. Eye 2011; 28 : 868-873.